[
    "{\"step_by_step_thinking\": \"To determine whether PET/CT adds something to multidetector CT in the preoperative staging of patients with liver metastases of colorectal carcinoma, we need to consider the advantages and limitations of each imaging modality. 1. Multidetector CT (MDCT) is commonly used for preoperative staging of liver metastases. It provides detailed anatomical information and can detect liver lesions based on their size, shape, and density. However, MDCT has limitations in detecting small lesions and differentiating between benign and malignant lesions. 2. PET/CT combines positron emission tomography (PET) and CT imaging. PET uses a radioactive tracer to detect metabolic activity in tissues, while CT provides anatomical information. PET/CT can detect small lesions and differentiate between benign and malignant lesions based on their metabolic activity. 3. Several studies have compared the diagnostic accuracy of PET/CT and MDCT in the preoperative staging of liver metastases. These studies have shown that PET/CT has higher sensitivity and specificity compared to MDCT, especially in detecting small lesions and differentiating between benign and malignant lesions. 4. PET/CT can also provide additional information about extrahepatic metastases, which may impact treatment decisions. Based on the above information, the answer is A. yes, PET/CT does add something to multidetector CT in the preoperative staging of patients with liver metastases of colorectal carcinoma.\", \"answer_choice\": \"A\"}"
]